CS Paper Radar

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna

cs.LG q-bio.QM ·submitted 2026-08-21 17:54 UTC · v1

Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

Closest papers

Nearest neighbours by meaning across the whole index.

CoRe-WM: Conditioned Response-State World Modeling for Longitudinal Treatment-Response Prediction in Breast DCE-MRI

cs.CV ·2026-10-18 ·Lin Zhao, Bowen Chen, Qiaohui Gao, Shaowen Wan, Xiang Li +2 more
similarity 0.73
Abstract

Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic indicator in aggressive breast cancer, yet existing prediction approaches either rely on pretreatment imaging alone, missing the patient's evolving response, or optimize multi-visit classifiers under direct outcome supervision, coupling representation learning with the clinical endpoint. We formulate longitudinal pCR prediction as a world-modeling problem and propose Conditioned Response-state World Modeling (CoRe-WM), which learns a latent state-transition model that predicts the next imaging state from the observed sequence. The transition function is conditioned on patient clinical profile and assigned therapy through additive shift and feature-wise modulation, enabling patient- and treatment-specific dynamics. A Factorized Response State pathway further decouples treatment-response dynamics from imaging appearance by encoding the structural prior that response manifests primarily in lesion morphology. After pretraining, all parameters are frozen and a linear readout predicts pCR at each clinical decision point. We evaluate CoRe-WM on I-SPY2 under five-fold cross-validation and assess cross-cohort transfer on I-SPY1. CoRe-WM achieves the highest discrimination among all evaluated methods at every prospective decision point, and demonstrates robust cross-cohort transfer. Ablation studies identify patient-profile conditioning and the factorized response pathway as the principal contributors. These results establish world-model-based representation learning as a promising framework for outcome prediction in oncology and beyond.

0.20

HiSTOR: Structured Treatment-outcome Representation Learning for High-Dimensional Longitudinal Data

cs.LG cs.AI ·2026-10-13 ·Chuanqi Lao, Junzhou Huang, Qiao Liu
similarity 0.71
Abstract

Estimating potential outcomes under alternative treatment sequences is essential for personalized decision-making, but remains challenging with high-dimensional covariates and time-varying confounding. In this study, we propose HiSTOR (High-dimensional Structured Treatment-Outcome Representation), an end-to-end framework that integrates nonlinear dimension reduction with longitudinal counterfactual prediction. The central idea is to learn structured low-dimensional representations of both current patient states and evolving histories, according to their shared and distinct relationships with treatment assignment and outcomes. This extends latent-space covariate adjustment to longitudinal settings, jointly addressing covariate dimensionality and historical complexity. The resulting framework supports one-step and multi-step outcome prediction under specified treatment sequences. Experiments on CVSim and CancerSim demonstrate the superiority of HiSTOR across varying covariate dimensions, confounding strengths, and prediction horizons compared to state-of-the-art methods. To sum up, HiSTOR offers a unified approach to connecting high-dimensional covariate adjustment with longitudinal potential-outcome prediction.

0.18

Learning Perturbation-Specific Representations through Conditional Energy Prior for Cellular Response Prediction

cs.LG cs.AI ·2026-10-13 ·Yuchen Yan, Yatao Bian
benchmarktheorycode/data similarity 0.71
Abstract

AI-based cellular perturbation prediction is essential to accelerate drug discovery and therapeutic identification. However, perturbation-specific signals are generally obscured by cellular complexity, making it difficult for existing methods to correctly capture perturbation effects. To address this problem, we propose PerturbEnergy, which introduces a conditional energy-based prior over perturbation representations. It assigns lower energy (higher probability) to representations compatible with the given perturbation and higher energy to others, thereby explicitly tilting the latent space toward perturbation-preferred regions. Besides, PerturbEnergy can be integrated into autoencoder architectures as we find its Evidence Lower Bound (ELBO) is equivalent to the ELBO of the complete autoencoder. We further prove that optimizing PerturbEnergy increases the lower bound on the conditional mutual information between representation and perturbation. Extensive experiments on four benchmark datasets demonstrate the effectiveness of our PerturbEnergy: it improves perturbation recognition especially in latent space with improvement of up to 83.2\%; It also achieves state-of-the-art performance for predicting top-50/100/200 differentially expressed gene(DEG) response and remaining competitive on highly variable gene(HVG) prediction. The code is provided: https://github.com/BlueWhaleLab/PerturbEnergy

0.34

PerturbJEPA: Joint-Embedding Predictive Learning of Cellular Perturbation Responses

cs.CV ·2026-11-16 ·Jiangshuan Pang, Youzhe He, Yiting Deng, Wangyang Tang, Huinan Xu +3 more
code/data similarity 0.70
Abstract · 23 pages, 6 figures, 14 tables. Code: https://github.com/BGI-Hangzhou-OmicsAI/PerturbJEPA

Identifying the drug and dose that produced a cellular response requires preserving treatment effects within each cellular background. A joint-embedding predictor can match its targets while ignoring the intervention if its encoder preserves differences across backgrounds but erases differences between treated and control populations within each one. We call this failure interventional contrast collapse. PerturbJEPA encodes the difference in mean gene expression between treated and control populations as an effect vector. It aligns the displacement between their latent centroids with this vector and regularizes the vectors to preserve variation across population pairs. We show that the measured displacements cannot all coincide within a batch when effect-vector variation exceeds the root-mean-square alignment error. Trained with separate drug and dose ranking objectives, the model predicts candidate responses from a common control population and matches them to the observed response without cell pairing or expression reconstruction. We evaluate 3,592 Tahoe-100M queries on held-out combinations of known interventions and cellular backgrounds, each with over 700 drug-dose candidates in a fixed, background-specific catalog. PerturbJEPA achieves 91.46% macro joint drug-dose Recall@1, exceeding STATE by 3.40 percentage points (95% drug-cluster bootstrap interval of 1.72 to 5.07 points). Controlled diagnostics show that treatment-control differences can shrink even when representations remain globally dispersed. With the drug ranking objective fixed, adding effect-vector regularization to alignment raises joint Recall@1 from 18.57% to 87.47%.

0.54

scDEFT: A deep learning framework for drug-effect prediction and counterfactual reasoning

cs.LG q-bio.QM ·2026-09-09 ·Murthy Devarakonda
similarity 0.70
Abstract · 21 Pages, 5 Figures, 3 Tables, and a Supplementary Notes section for overflow material. Approximately 3000 words (excluding Figures, Tables,…

Longitudinal single cell atlases now capture matched pre treatment and post treatment states from responders and non responders, presenting an opportunity to mechanistically explain why two patients on the same drug diverge. We introduce scDEFT (single cell Drug EFfect Transducer), which treats a drug as a conditioning operator on cell representations, enabling prediction and explanation. In scDEFT, feature wise linear modulation produces drug conditioned cell latents, learned under abundant per cell supervision and then frozen. Two independent heads aggregate those latents over shared transcriptional neighborhoods to predict drug induced state change and responder status. A backward stage ranks the latent dimensions by how strongly they separate responders from non responders and maps them to genes under a cell composition control. On a harmonized inflammatory bowel disease atlas of 1.16 million cells, three cohorts and two drug classes, scDEFT predicts state change at 45% of the baseline to reproducibility ceiling headroom and stratifies responders before treatment at AUROC 0.70, where standard predictors remain at chance. These predictions and the drivers behind them support target and co target nomination, patient stratification, and counterfactual prediction of unseen drug cohort effects.

0.12

CytoWave: Perturbation-Centric Pretraining for Single-Cell Response Prediction

cs.LG ·2026-11-02 ·Yuwei Miao, Jingquan Yan, Hehuan Ma, Thao M. Dang, Lin Xu +2 more
top venuehot direction similarity 0.67
Abstract · Accepted by NeurIPS 2026

Predicting gene expression under perturbations from single-cell data is a fundamental task for modeling cellular responses, with applications in discovering gene function and designing therapeutics. However, existing methods often struggle to generalize across datasets due to differences in experimental protocols, biological contexts, and species. We present \textbf{CytoWave}, a perturbation-centric pretraining framework for single-cell genetic perturbation response prediction. We leverage large-scale cross-species perturbation datasets unified via orthology and train CytoWave in a two-stage manner. In the first stage, we learn reference control cell states via masked gene expression recovery on unperturbed cells. In the second stage, we pretrain the model to predict perturbed gene expression given control states and perturbation signals, together with a contrastive objective that aligns latent representations of perturbation responses with perturbation signals. We perform strict dataset-held-out evaluation across multiple condition combinations and case studies of pathway activity changes, demonstrating consistent and effective performance of CytoWave in predicting single-cell genetic perturbation responses.

0.38

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

cs.CV cs.LG ·2026-10-17 ·Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He
similarity 0.67
Abstract · 30 pages,8 figures,12 tables,including supplementary material

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

0.33

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.66
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33